Gene · 6358
Papers2,754
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
681 to 700 of 2,754
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| A BET Protein Inhibitor Targeting Mononuclear Myeloid Cells Affects Specific Inflammatory Mediators and Pathways in Crohn's Disease. | Cells | 2022 | 36139421 | PubTator, text mining | PubMed |
| Single cell atlas identifies lipid-processing and immunomodulatory endothelial cells in healthy and malignant breast. | Nat Commun | 2022 | 36127427 | PubTator, text mining | PubMed |
| Molecular architecture of the augmin complex. | Nat Commun | 2022 | 36114186 | PubTator, text mining | PubMed |
| Molecular architecture of the autoinhibited kinesin-1 lambda particle. | Sci Adv | 2022 | 36112680 | PubTator, text mining | PubMed |
Inhibition of APOC1 promotes the transformation of M2 into M1 macrophages via the ferroptosis pathway and enhances anti-PD1 immunotherapy in hepatocellular carcinoma based on single-cell RNA sequencing. | Redox Biol | 2022 | 36108528 | PubTator, text mining | PubMed |
| Conformational transitions of the Spindly adaptor underlie its interaction with Dynein and Dynactin. | J Cell Biol | 2022 | 36107127 | PubTator, text mining | PubMed |
| Impact of the Anthryl Linking Mode on the Photophysics and Excited-State Dynamics of Re(I) Complexes [ReCl(CO)3(4'-An-terpy-κ2N)]. | Inorg Chem | 2022 | 36101987 | PubTator, text mining | PubMed |
| Comparing swab- and different symptoms-based strategies to ascertain COVID-19 recovery in healthcare workers: a cost-effectiveness analysis. | Cost Eff Resour Alloc | 2022 | 36096794 | PubTator, text mining | PubMed |
| An integrative analysis revealing POLD2 as a tumor suppressive immune protein and prognostic biomarker in pan-cancer. | Front Genet | 2022 | 36081989 | PubTator, text mining | PubMed |
| Strength of Partially Encased Steel-Concrete Composite Column for Modular Building Structures. | Materials (Basel) | 2022 | 36079427 | PubTator, text mining | PubMed |
| A Single-Cell Survey of Cellular Heterogeneity in Human Great Saphenous Veins. | Cells | 2022 | 36078120 | PubTator, text mining | PubMed |
| Distinctive exercise-induced inflammatory response and exerkine induction in skeletal muscle of people with type 2 diabetes. | Sci Adv | 2022 | 36070371 | PubTator, text mining | PubMed |
| Correction: E47 upregulates ΔNp63α to promote growth of squamous cell carcinoma. | Cell Death Dis | 2022 | 36068194 | PubTator, text mining | PubMed |
| Integrated analysis of the expression profiles of the lncRNA-miRNA-mRNA ceRNA network in granulosa and cumulus cells from yak ovaries. | BMC Genomics | 2022 | 36057545 | PubTator, text mining | PubMed |
| A universal co-expression gene network and prognostic model for hepatic-biliary-pancreatic cancers identified by integrative analyses. | FEBS Open Bio | 2022 | 36054420 | PubTator, text mining | PubMed |
| Subphenotypes of acute kidney injury in children. | Curr Opin Crit Care | 2022 | 36044290 | PubTator, text mining | PubMed |
| On the Design of Secured and Reliable Dynamic Access Control Scheme of Patient E-Healthcare Records in Cloud Environment. | Comput Intell Neurosci | 2022 | 36035822 | PubTator, text mining | PubMed |
| An inflammation-related signature could predict the prognosis of patients with kidney renal clear cell carcinoma. | Front Genet | 2022 | 36035192 | PubTator, text mining | PubMed |
| In Vitro and In Silico Potential Inhibitory Effects of New Biflavonoids from Ochna rhizomatosa on HIV-1 Integrase and Plasmodium falciparum. | Pharmaceutics | 2022 | 36015326 | PubTator, text mining | PubMed |
| The Catalytic Subunit of Schizosaccharomyces pombe CK2 (Cka1) Negatively Regulates RNA Polymerase II Transcription through Phosphorylation of Positive Cofactor 4 (PC4). | Int J Mol Sci | 2022 | 36012759 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/6358/papers?page=35